Article Details
Retrieved on: 2021-07-27 15:44:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Since 2017, the FDA has cleared Keytruda and Roche's Tecentriq for triple-negative tumors that have already spread. Both companies have worked to ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here